MAPT and Alzheimer disease: There are up to 85 sites at which tau can be phosphorylated (Martin et al., 2011), with the three most widely investigated sites in relation to AD being tau phosphorylated at threonine 181 (p-tau181), threonine 217 (p-tau217), and threonine 231 (p-tau231).